Aripiprazole in psychosis associated with Parkinson's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 17, Issue 3, 2005, Pages 421-422

  López Meza, Elmer ^a   Ruiz Chow, Angel ^a   Ramirez Bermudez, Jesus ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENSERAZIDE; BIPERIDEN; BROMOCRIPTINE; CARBIDOPA; CLOZAPINE; LEVODOPA; LORAZEPAM; OLANZAPINE; VENLAFAXINE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; MENTAL DISEASE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE;

AGED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PARKINSON DISEASE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES;

EID: 85047696491     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.17.3.421     Document Type: Article

References (10)

1. Juncos JL: Management of psychotic aspects of Parkinson's disease. J Clin Psychiatry 1999; 60 Suppl 8:42-53
2. Wolters EC, Berendse HW: Management of psychosis in Parkinson's disease. Curr Opin Neurol 2001; 14(4):499-504
3. Factor SA, Feustel PJ, Friedman JH, et al: Parkinson Study Group. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003; 60(11):1756-1761
4. Rabey JM, Treves TA, Neufeld MY, et al: Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease. Neurology 1995; 45(3 Pt 1):432-434
5. Cummings JL: Managing psychosis in patients with Parkinson's disease. N Engl J Med 1999; 340(10):801-803
6. Factor SA, Brown D, Molho ES, et al: Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis. Neurology 1994; 44(3):544-546
7. Potkin SG, Saha AR, Kujawa MJ, et al: Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2003; 60(7):681-690
8. Fernandez HH, Trieschmann ME, Friedman JH: Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience. Clin Neuropharmacol 2004; 27:4-5
9. Schonfeldt-Lecuona C, Connemann BJ: Aripiprazole and Parkinson's disease psychosis. Am J Psychiatry 2004; 161:373-374
10. Alexopoulos GS, Streim J, Carpenter D, et al: Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. J Clin Psychiatry 2004; 65 (suppl) 2:5-99; discussion 100-102; quiz 103-104